Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 246

1.

Perioperative Outcomes of Melanoma Patients Undergoing Surgery After Receiving Immunotherapy or Targeted Therapy.

Sun J, Kirichenko DA, Chung JL, Carr MJ, Eroglu Z, Khushalani NI, Markowitz J, Messina JL, Sondak VK, Zager JS, Patel SY.

World J Surg. 2019 Dec 6. doi: 10.1007/s00268-019-05314-2. [Epub ahead of print]

PMID:
31811340
2.

Translational pathology, genomics and the development of systemic therapies for acral melanoma.

Chen YA, Teer JK, Eroglu Z, Wu JY, Koomen JM, Karreth FA, Messina JL, Smalley KSM.

Semin Cancer Biol. 2019 Nov 2. pii: S1044-579X(19)30343-8. doi: 10.1016/j.semcancer.2019.10.017. [Epub ahead of print] Review.

PMID:
31689494
3.

Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma.

Smalley I, Kim E, Li J, Spence P, Wyatt CJ, Eroglu Z, Sondak VK, Messina JL, Babacan NA, Maria-Engler SS, De Armas L, Williams SL, Gatenby RA, Chen YA, Anderson ARA, Smalley KSM.

EBioMedicine. 2019 Oct;48:178-190. doi: 10.1016/j.ebiom.2019.09.023. Epub 2019 Oct 5.

4.

Viruses in Skin Cancer (VIRUSCAN): Study design and baseline characteristics of a prospective clinic-based cohort study.

Amorrortu RP, Fenske NA, Cherpelis BS, Vijayan L, Zhao Y, Balliu J, Messina JL, Sondak VK, Giuliano AR, Gheit T, Tommasino M, Rollison DE.

Cancer Epidemiol Biomarkers Prev. 2019 Aug 19. pii: cebp.0446.2019. doi: 10.1158/1055-9965.EPI-19-0446. [Epub ahead of print]

PMID:
31427307
5.

Re-biopsy of partially sampled thin melanoma impacts sentinel lymph node sampling as well as surgical margins.

Weitman ES, Perez MC, Lee D, Kim Y, Fulp W, Sondak VK, Sarnaik AA, Gonzalez RJ, Cruse CW, Messina JL, Zager JS.

Melanoma Manag. 2019 Apr 26;6(2):MMT17. doi: 10.2217/mmt-2018-0011. eCollection 2019 Jun.

6.

The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy.

Knepper TC, Montesion M, Russell JS, Sokol ES, Frampton GM, Miller VA, Albacker LA, McLeod HL, Eroglu Z, Khushalani NI, Sondak VK, Messina JL, Schell MJ, DeCaprio JA, Tsai KY, Brohl AS.

Clin Cancer Res. 2019 Oct 1;25(19):5961-5971. doi: 10.1158/1078-0432.CCR-18-4159. Epub 2019 Aug 9.

PMID:
31399473
7.

Recurrence of Melanoma After a Negative Sentinel Node Biopsy: Predictors and Impact of Recurrence Site on Survival.

Thomas DC, Han G, Leong SP, Kashani-Sabet M, Vetto J, Pockaj B, White RL, Faries MB, Schneebaum S, Mozzillo N, Charney KJ, Sondak VK, Messina JL, Zager JS, Han D.

Ann Surg Oncol. 2019 Jul;26(7):2254-2262. doi: 10.1245/s10434-019-07369-w. Epub 2019 Apr 22.

PMID:
31011906
8.

HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor Therapy.

Emmons MF, Faião-Flores F, Sharma R, Thapa R, Messina JL, Becker JC, Schadendorf D, Seto E, Sondak VK, Koomen JM, Chen YA, Lau EK, Wan L, Licht JD, Smalley KSM.

Cancer Res. 2019 Jun 1;79(11):2947-2961. doi: 10.1158/0008-5472.CAN-19-0040. Epub 2019 Apr 15.

PMID:
30987999
9.

Completion lymphadenectomy for a positive sentinel node biopsy in melanoma patients is not associated with a survival benefit.

Klemen ND, Han G, Leong SP, Kashani-Sabet M, Vetto J, White R, Schneebaum S, Pockaj B, Mozzillo N, Charney K, Hoekstra H, Sondak VK, Messina JL, Zager JS, Han D.

J Surg Oncol. 2019 Jun;119(8):1053-1059. doi: 10.1002/jso.25444. Epub 2019 Mar 18.

PMID:
30883771
10.

BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells.

Atay C, Kwak T, Lavilla-Alonso S, Donthireddy L, Richards A, Moberg V, Pilon-Thomas S, Schell M, Messina JL, Rebecca VW, Xiao M, Tan J, Zhang G, Weber JS, Herlyn M, Sarnaik AA, Gabrilovich DI.

Clin Cancer Res. 2019 May 1;25(9):2783-2794. doi: 10.1158/1078-0432.CCR-18-2725. Epub 2019 Feb 14.

PMID:
30765391
11.

Management of intussusception in patients with melanoma.

Perez MC, Sun J, Farley C, Han D, Sun AH, Narayan D, Lowe M, Delman KA, Messina JL, Gonzalez RJ, Sondak VK, Khushalani NI, Zager JS.

J Surg Oncol. 2019 Jun;119(7):897-902. doi: 10.1002/jso.25393. Epub 2019 Feb 7.

PMID:
30734297
12.

Melanocortin 1 Receptor-Targeted α-Particle Therapy for Metastatic Uveal Melanoma.

Tafreshi NK, Tichacek CJ, Pandya DN, Doligalski ML, Budzevich MM, Kil H, Bhatt NB, Kock ND, Messina JL, Ruiz EE, Delva NC, Weaver A, Gibbons WR, Boulware DC, Khushalani NI, El-Haddad G, Triozzi PL, Moros EG, McLaughlin ML, Wadas TJ, Morse DL.

J Nucl Med. 2019 Aug;60(8):1124-1133. doi: 10.2967/jnumed.118.217240. Epub 2019 Feb 7.

PMID:
30733316
13.

Performance of a 31-gene expression profile test in cutaneous melanomas of the head and neck.

Gastman BR, Zager JS, Messina JL, Cook RW, Covington KR, Middlebrook B, Gerami P, Wayne JD, Leachman S, Vetto JT.

Head Neck. 2019 Apr;41(4):871-879. doi: 10.1002/hed.25473. Epub 2019 Jan 29.

14.

Cross-sectional associations between cutaneous viral infections and regulatory T lymphocytes in circulation.

Hampras SS, Tommasino M, Zhao Y, Messina JL, Giuliano AR, Fenske NA, Cherpelis B, Hesterberg RS, Akuffo AA, Amorrortu RP, Balliu J, Vijayan L, Gheit T, Epling-Burnette PK, Rollison DE.

Br J Dermatol. 2019 Jun;180(6):1449-1458. doi: 10.1111/bjd.17429. Epub 2019 Feb 10.

PMID:
30431148
15.

Microsatellitosis in Patients with Melanoma.

Karakousis GC, Gimotty PA, Leong SP, Pockaj BA, White RL, O'Donoghue C, Sinnamon AJ, Bartlett EK, Dueck AC, Gould Rothberg BE, Messina JL, Vetto JT, Sondak VK, Schneebaum S, Kashani-Sabet M, Han D, Faries MB, Zager JS; with the Sentinel Lymph Node Working Group.

Ann Surg Oncol. 2019 Jan;26(1):33-41. doi: 10.1245/s10434-018-7006-4. Epub 2018 Nov 12.

PMID:
30421045
16.

PTPN11 Plays Oncogenic Roles and Is a Therapeutic Target for BRAF Wild-Type Melanomas.

Hill KS, Roberts ER, Wang X, Marin E, Park TD, Son S, Ren Y, Fang B, Yoder S, Kim S, Wan L, Sarnaik AA, Koomen JM, Messina JL, Teer JK, Kim Y, Wu J, Chalfant CE, Kim M.

Mol Cancer Res. 2019 Feb;17(2):583-593. doi: 10.1158/1541-7786.MCR-18-0777. Epub 2018 Oct 24.

PMID:
30355677
17.

Management of Sentinel Lymph Node Metastasis in Merkel Cell Carcinoma: Completion Lymphadenectomy, Radiation, or Both?

Perez MC, Oliver DE, Weitman ES, Boulware D, Messina JL, Torres-Roca J, Cruse CW, Gonzalez RJ, Sarnaik AA, Sondak VK, Wuthrick EJ, Harrison LB, Zager JS.

Ann Surg Oncol. 2019 Feb;26(2):379-385. doi: 10.1245/s10434-018-6810-1. Epub 2018 Oct 11.

PMID:
30311164
18.

Cutaneous Viral Infections Across 2 Anatomic Sites Among a Cohort of Patients Undergoing Skin Cancer Screening.

Rollison DE, Schell MJ, Fenske NA, Cherpelis B, Messina JL, Giuliano AR, Epling-Burnette PK, Hampras SS, Amorrortu RP, Balliu J, Vijayan L, Naqvi SMH, Zhao Y, Parab K, McKay-Chopin S, Gheit T, Tommasino M.

J Infect Dis. 2019 Feb 15;219(5):711-722. doi: 10.1093/infdis/jiy577.

PMID:
30260406
19.

Interferon is associated with improved survival for node-positive cutaneous melanoma: a single-institution experience.

Oliver DE, Sondak VK, Strom T, Zager JS, Naghavi AO, Sarnaik A, Messina JL, Caudell JJ, Trotti AM, Torres-Roca JF, Khushalani NI, Harrison LB.

Melanoma Manag. 2018 Apr 9;5(1):MMT02. doi: 10.2217/mmt-2017-0025. eCollection 2018 Jun.

20.

Resection Margins in Merkel Cell Carcinoma: Is a 1-cm Margin Wide Enough?

Perez MC, de Pinho FR, Holstein A, Oliver DE, Naqvi SMH, Kim Y, Messina JL, Burke E, Gonzalez RJ, Sarnaik AA, Cruse CW, Wuthrick EJ, Harrison LB, Sondak VK, Zager JS.

Ann Surg Oncol. 2018 Oct;25(11):3334-3340. doi: 10.1245/s10434-018-6688-y. Epub 2018 Aug 2.

PMID:
30073600
21.

Pathologic analysis of melanocytic neoplasms.

Messina JL, Gibbs J.

Semin Cutan Med Surg. 2018 Jun;37(2):88-100. doi: 10.12788/j.sder.2017.054. Review.

PMID:
30040085
22.

Behavior of Cutaneous Adnexal Malignancies: a Single Institution Experience.

Prieto-Granada C, Castner N, Chen A, Li J, Yue B, Wong JY, Iyengar S, Sondak VK, Zager JS, Messina JL.

Pathol Oncol Res. 2018 Jun 14. doi: 10.1007/s12253-018-0427-3. [Epub ahead of print]

PMID:
29948620
23.

Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma.

Tetzlaff MT, Messina JL, Stein JE, Xu X, Amaria RN, Blank CU, van de Wiel BA, Ferguson PM, Rawson RV, Ross MI, Spillane AJ, Gershenwald JE, Saw RPM, van Akkooi ACJ, van Houdt WJ, Mitchell TC, Menzies AM, Long GV, Wargo JA, Davies MA, Prieto VG, Taube JM, Scolyer RA.

Ann Oncol. 2018 Aug 1;29(8):1861-1868. doi: 10.1093/annonc/mdy226.

24.

Combined BRAF and HSP90 Inhibition in Patients with Unresectable BRAF V600E-Mutant Melanoma.

Eroglu Z, Chen YA, Gibney GT, Weber JS, Kudchadkar RR, Khushalani NI, Markowitz J, Brohl AS, Tetteh LF, Ramadan H, Arnone G, Li J, Zhao X, Sharma R, Darville LNF, Fang B, Smalley I, Messina JL, Koomen JM, Sondak VK, Smalley KSM.

Clin Cancer Res. 2018 Nov 15;24(22):5516-5524. doi: 10.1158/1078-0432.CCR-18-0565. Epub 2018 Apr 19.

25.

Stratifying SLN incidence in intermediate thickness melanoma patients.

Chang JM, Kosiorek HE, Dueck AC, Leong SPL, Vetto JT, White RL, Avisar E, Sondak VK, Messina JL, Zager JS, Garberoglio C, Kashani-Sabet M, Pockaj BA.

Am J Surg. 2018 Apr;215(4):699-706. doi: 10.1016/j.amjsurg.2017.12.009. Epub 2017 Dec 14.

26.

Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients.

Zager JS, Gastman BR, Leachman S, Gonzalez RC, Fleming MD, Ferris LK, Ho J, Miller AR, Cook RW, Covington KR, Meldi-Plasseraud K, Middlebrook B, Kaminester LH, Greisinger A, Estrada SI, Pariser DM, Cranmer LD, Messina JL, Vetto JT, Wayne JD, Delman KA, Lawson DH, Gerami P.

BMC Cancer. 2018 Feb 5;18(1):130. doi: 10.1186/s12885-018-4016-3.

27.

Genomic analysis of a case of agminated Spitz nevi and congenital-pattern nevi arising in extensive nevus spilus.

Porubsky C, Teer JK, Zhang Y, Deschaine M, Sondak VK, Messina JL.

J Cutan Pathol. 2018 Feb;45(2):180-183. doi: 10.1111/cup.13082. Epub 2017 Dec 17.

28.

Insulin attenuates TNFα-induced hemopexin mRNA: An anti-inflammatory action of insulin in rat H4IIE hepatoma cells.

Franklin JL, Bennett WL, Messina JL.

Biochem Biophys Rep. 2017 Jan 5;9:211-216. doi: 10.1016/j.bbrep.2016.12.013. eCollection 2017 Mar.

29.

Submammary Granular Parakeratosis Treated With Mastopexy.

Nelson G, Lien MH, Messina JL, Ranjit S, Fenske NA.

J Drugs Dermatol. 2017 Aug 1;16(8):810-812.

PMID:
28809996
30.

Selecting Patients With Thin Melanoma for Sentinel Lymph Node Biopsy-This Time It's Personal.

Sondak VK, Messina JL, Zager JS.

JAMA Dermatol. 2017 Sep 1;153(9):857-858. doi: 10.1001/jamadermatol.2017.2496. No abstract available.

PMID:
28724141
31.

Polytrauma-induced hepatic stress response and the development of liver insulin resistance.

Akscyn RM, Franklin JL, Gavrikova TA, Messina JL.

Biochim Biophys Acta Mol Basis Dis. 2017 Oct;1863(10 Pt B):2672-2679. doi: 10.1016/j.bbadis.2017.05.009. Epub 2017 May 10.

32.

Regional Radiation Therapy Impacts Outcome for Node-Positive Cutaneous Melanoma.

Strom T, Torres-Roca JF, Parekh A, Naghavi AO, Caudell JJ, Oliver DE, Messina JL, Khushalani NI, Zager JS, Sarnaik A, Mulé JJ, Trotti AM, Eschrich SA, Sondak VK, Harrison LB.

J Natl Compr Canc Netw. 2017 Apr;15(4):473-482.

PMID:
28404758
33.

Treatment of Head and Neck Melanoma In Situ With Staged Contoured Marginal Excisions.

Glazer ES, Porubsky CF, Francis JD, Ibanez J, Castner N, Messina JL, Sarnaik AA, Harrington MA, Cruse CW, Sondak VK, Zager JS.

Ann Plast Surg. 2017 Jun;78(6):663-667. doi: 10.1097/SAP.0000000000000949.

34.

Primary cutaneous adenoid cystic carcinoma with MYB aberrations: report of three cases and comprehensive review of the literature.

Prieto-Granada CN, Zhang L, Antonescu CR, Henneberry JM, Messina JL.

J Cutan Pathol. 2017 Feb;44(2):201-209. doi: 10.1111/cup.12856. Epub 2016 Dec 2.

35.

Country-specific HPV-related genital disease among men residing in Brazil, Mexico and The United States: The HIM study.

Sudenga SL, Torres BN, Fulp WJ, Silva R, Villa LL, Lazcano-Ponce E, Ingles DJ, Stoler M, Messina JL, Abrahamsen M, Baggio ML, Salmeron J, Quiterio M, Giuliano AR.

Int J Cancer. 2017 Jan 15;140(2):337-345. doi: 10.1002/ijc.30452. Epub 2016 Oct 20.

36.

Comparing whole slide digital images versus traditional glass slides in the detection of common microscopic features seen in dermatitis.

Vyas NS, Markow M, Prieto-Granada C, Gaudi S, Turner L, Rodriguez-Waitkus P, Messina JL, Jukic DM.

J Pathol Inform. 2016 Jul 26;7:30. doi: 10.4103/2153-3539.186909. eCollection 2016.

37.

Cutaneous beta human papillomaviruses and the development of male external genital lesions: A case-control study nested within the HIM Study.

Pierce Campbell CM, Gheit T, Tommasino M, Lin HY, Torres BN, Messina JL, Stoler MH, Rollison DE, Sirak BA, Abrahamsen M, Carvalho da Silva RJ, Sichero L, Villa LL, Lazcano-Ponce E, Giuliano AR.

Virology. 2016 Oct;497:314-322. doi: 10.1016/j.virol.2016.08.002. Epub 2016 Aug 10.

38.

A Comprehensive Approach to Pediatric Atypical Melanocytic Neoplasms with Comment on the Role of Sentinel Lymph Node Biopsy.

Sondak VK, Reed D, Messina JL.

Crit Rev Oncog. 2016;21(1-2):25-36. doi: 10.1615/CritRevOncog.2016016109. Review.

PMID:
27481000
39.

IgG4-related skin disease may have distinct systemic manifestations: a systematic review.

Bennett AE, Fenske NA, Rodriguez-Waitkus P, Messina JL.

Int J Dermatol. 2016 Nov;55(11):1184-1195. doi: 10.1111/ijd.13369. Review.

PMID:
27419384
40.

Improved local and regional control with radiotherapy for Merkel cell carcinoma of the head and neck.

Strom T, Naghavi AO, Messina JL, Kim S, Torres-Roca JF, Russell J, Sondak VK, Padhya TA, Trotti AM, Caudell JJ, Harrison LB.

Head Neck. 2017 Jan;39(1):48-55. doi: 10.1002/hed.24527. Epub 2016 Jun 14.

PMID:
27300153
41.

Radiation Therapy is Associated with Improved Outcomes in Merkel Cell Carcinoma.

Strom T, Carr M, Zager JS, Naghavi A, Smith FO, Cruse CW, Messina JL, Russell J, Rao NG, Fulp W, Kim S, Torres-Roca JF, Padhya TA, Sondak VK, Trotti AM, Harrison LB, Caudell JJ.

Ann Surg Oncol. 2016 Oct;23(11):3572-3578. doi: 10.1245/s10434-016-5293-1. Epub 2016 Jun 1.

PMID:
27251134
42.

Prediction is Difficult, Especially About the Future: Clinical Prognostic Tools in Melanoma.

Sondak VK, Messina JL.

Ann Surg Oncol. 2016 Sep;23(9):2730-2. doi: 10.1245/s10434-016-5213-4. Epub 2016 May 19. No abstract available.

PMID:
27198510
43.

Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group.

Lott JP, Elmore JG, Zhao GA, Knezevich SR, Frederick PD, Reisch LM, Chu EY, Cook MG, Duncan LM, Elenitsas R, Gerami P, Landman G, Lowe L, Messina JL, Mihm MC, van den Oord JJ, Rabkin MS, Schmidt B, Shea CR, Yun SJ, Xu GX, Piepkorn MW, Elder DE, Barnhill RL; International Melanoma Pathology Study Group.

J Am Acad Dermatol. 2016 Aug;75(2):356-63. doi: 10.1016/j.jaad.2016.04.052. Epub 2016 May 14.

44.

Prenylation differentially inhibits insulin-dependent immediate early gene mRNA expression.

Franklin JL, Amsler MO, Messina JL.

Biochem Biophys Res Commun. 2016 Jun 3;474(3):594-598. doi: 10.1016/j.bbrc.2016.04.067. Epub 2016 Apr 14.

45.

Inactivation of RASA1 promotes melanoma tumorigenesis via R-Ras activation.

Sung H, Kanchi KL, Wang X, Hill KS, Messina JL, Lee JH, Kim Y, Dees ND, Ding L, Teer JK, Yang S, Sarnaik AA, Sondak VK, Mulé JJ, Wilson RK, Weber JS, Kim M.

Oncotarget. 2016 Apr 26;7(17):23885-96. doi: 10.18632/oncotarget.8127.

46.

Is a Wider Margin (2 cm vs. 1 cm) for a 1.01-2.0 mm Melanoma Necessary?

Doepker MP, Thompson ZJ, Fisher KJ, Yamamoto M, Nethers KW, Harb JN, Applebaum MA, Gonzalez RJ, Sarnaik AA, Messina JL, Sondak VK, Zager JS.

Ann Surg Oncol. 2016 Jul;23(7):2336-42. doi: 10.1245/s10434-016-5167-6. Epub 2016 Mar 8.

47.

A rat model of concurrent combined injuries (polytrauma).

Akscyn RM, Franklin JL, Gavrikova TA, Schwacha MG, Messina JL.

Int J Clin Exp Med. 2015 Nov 15;8(11):20097-110. eCollection 2015.

48.

Skeletal muscle atrogene expression and insulin resistance in a rat model of polytrauma.

Akscyn RM, Franklin JL, Gavrikova TA, Messina JL.

Physiol Rep. 2016 Feb;4(2). pii: e12659. doi: 10.14814/phy2.12659.

49.

BRAF inhibition for advanced locoregional BRAF V600E mutant melanoma: a potential neoadjuvant strategy.

Sloot S, Zager JS, Kudchadkar RR, Messina JL, Benedict JJ, Gonzalez RJ, DeConti R, Turner LM, McCardle T, Smalley KS, Weber JS, Sondak VK, Gibney GT.

Melanoma Res. 2016 Feb;26(1):83-7. doi: 10.1097/CMR.0000000000000214.

PMID:
26731560
50.

Dermal melanoma: A report on prognosis, outcomes, and the utility of sentinel lymph node biopsy.

Doepker MP, Thompson ZJ, Harb JN, Messina JL, Puleo CA, Egan KM, Sarnaik AA, Gonzalez RJ, Sondak VK, Zager JS.

J Surg Oncol. 2016 Jan;113(1):98-102. doi: 10.1002/jso.24088. Epub 2015 Dec 10.

Supplemental Content

Loading ...
Support Center